Total submissions: 22
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172744 | SCV000055128 | benign | Primary dilated cardiomyopathy | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000037232 | SCV000060889 | benign | not specified | 2012-01-24 | criteria provided, single submitter | clinical testing | Val459Ile in exon 9 of DES: This variant is classified as benign based on its hi gh frequency in the general population (NHLBI Exome Sequencing Project, http://e vs.gs.washington.edu/EVS; dbSNP rs73991549). |
Eurofins Ntd Llc |
RCV000037232 | SCV000111846 | benign | not specified | 2013-03-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000037232 | SCV000168103 | benign | not specified | 2017-04-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001084307 | SCV000287218 | benign | Desmin-related myofibrillar myopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000037232 | SCV000308536 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000248138 | SCV000319162 | benign | Cardiovascular phenotype | 2016-03-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001084307 | SCV000427738 | likely benign | Desmin-related myofibrillar myopathy | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000366607 | SCV000427739 | likely benign | Neurogenic scapuloperoneal syndrome, Kaeser type | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Illumina Laboratory Services, |
RCV000271115 | SCV000427740 | likely benign | Myofibrillar Myopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000307505 | SCV000427741 | likely benign | Dilated cardiomyopathy 1I | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
CHEO Genetics Diagnostic Laboratory, |
RCV000770175 | SCV000901602 | benign | Cardiomyopathy | 2023-05-16 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000056791 | SCV001159399 | benign | not provided | 2019-11-20 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000037232 | SCV001475070 | benign | not specified | 2020-02-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000056791 | SCV004033857 | benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | DES: BS1, BS2 |
Epithelial Biology; Institute of Medical Biology, |
RCV000056791 | SCV000087904 | not provided | not provided | no assertion provided | not provided | ||
Genetic Services Laboratory, |
RCV000037232 | SCV000150951 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000056791 | SCV001744775 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000037232 | SCV001921060 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000037232 | SCV001931027 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000037232 | SCV001959980 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000037232 | SCV001969285 | benign | not specified | no assertion criteria provided | clinical testing |